WO2000071679A3 - Human oxidoreductase proteins - Google Patents
Human oxidoreductase proteins Download PDFInfo
- Publication number
- WO2000071679A3 WO2000071679A3 PCT/US2000/013879 US0013879W WO0071679A3 WO 2000071679 A3 WO2000071679 A3 WO 2000071679A3 US 0013879 W US0013879 W US 0013879W WO 0071679 A3 WO0071679 A3 WO 0071679A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- oxrd
- oxidoreductase proteins
- human oxidoreductase
- provides
- proteins
- Prior art date
Links
- 102000004316 Oxidoreductases Human genes 0.000 title abstract 2
- 108090000854 Oxidoreductases Proteins 0.000 title abstract 2
- 239000000556 agonist Substances 0.000 abstract 1
- 239000005557 antagonist Substances 0.000 abstract 1
- 239000013604 expression vector Substances 0.000 abstract 1
- 102000040430 polynucleotide Human genes 0.000 abstract 1
- 108091033319 polynucleotide Proteins 0.000 abstract 1
- 239000002157 polynucleotide Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/0004—Oxidoreductases (1.)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Biomedical Technology (AREA)
- Genetics & Genomics (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Peptides Or Proteins (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Enzymes And Modification Thereof (AREA)
Abstract
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP00932647A EP1183370A2 (en) | 1999-05-20 | 2000-05-19 | Human oxidoreductase proteins |
AU50342/00A AU5034200A (en) | 1999-05-20 | 2000-05-19 | Oxidoreductase proteins |
JP2000620057A JP2003517288A (en) | 1999-05-20 | 2000-05-19 | Oxidoreductase protein |
CA002374413A CA2374413A1 (en) | 1999-05-20 | 2000-05-19 | Human oxidoreductase proteins |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US13504999P | 1999-05-20 | 1999-05-20 | |
US60/135,049 | 1999-05-20 | ||
US13674099P | 1999-05-27 | 1999-05-27 | |
US60/136,740 | 1999-05-27 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2000071679A2 WO2000071679A2 (en) | 2000-11-30 |
WO2000071679A3 true WO2000071679A3 (en) | 2001-07-05 |
Family
ID=26832934
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2000/013879 WO2000071679A2 (en) | 1999-05-20 | 2000-05-19 | Human oxidoreductase proteins |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP1183370A2 (en) |
JP (1) | JP2003517288A (en) |
AU (1) | AU5034200A (en) |
CA (1) | CA2374413A1 (en) |
WO (1) | WO2000071679A2 (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20020034783A1 (en) * | 2000-04-18 | 2002-03-21 | Rachel Meyers | 39228, a novel human alcohol dehydrogenase and uses therefor |
US20020001807A1 (en) * | 2000-03-31 | 2002-01-03 | Meyers Rachel A. | 21509 and 33770, novel human dehydrogenase family members and uses thereof |
EP1331227A1 (en) * | 2002-01-24 | 2003-07-30 | Millennium Pharmaceuticals, Inc. | 62113, A human acyl-CoA dehydrogenase family member and uses therefor |
US20070037193A1 (en) * | 2005-08-12 | 2007-02-15 | Rong-Hwa Lin | Modulation of peroxisome proliferator-activated receptors |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1996008568A2 (en) * | 1994-09-12 | 1996-03-21 | The Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services | CLONING AND EXPRESSION OF cDNA FOR HUMAN DIHYDROPYRIMIDINE DEHYDROGENASE |
WO1998020137A1 (en) * | 1996-11-07 | 1998-05-14 | Inctye Pharmaceuticals, Inc. | Human squalene epoxidase |
WO1998045435A2 (en) * | 1997-04-10 | 1998-10-15 | Genetics Institute, Inc. | SECRETED EXPRESSED SEQUENCE TAGS (sESTs) |
-
2000
- 2000-05-19 AU AU50342/00A patent/AU5034200A/en not_active Abandoned
- 2000-05-19 CA CA002374413A patent/CA2374413A1/en not_active Abandoned
- 2000-05-19 WO PCT/US2000/013879 patent/WO2000071679A2/en not_active Application Discontinuation
- 2000-05-19 JP JP2000620057A patent/JP2003517288A/en active Pending
- 2000-05-19 EP EP00932647A patent/EP1183370A2/en not_active Withdrawn
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1996008568A2 (en) * | 1994-09-12 | 1996-03-21 | The Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services | CLONING AND EXPRESSION OF cDNA FOR HUMAN DIHYDROPYRIMIDINE DEHYDROGENASE |
WO1998020137A1 (en) * | 1996-11-07 | 1998-05-14 | Inctye Pharmaceuticals, Inc. | Human squalene epoxidase |
WO1998045435A2 (en) * | 1997-04-10 | 1998-10-15 | Genetics Institute, Inc. | SECRETED EXPRESSED SEQUENCE TAGS (sESTs) |
Non-Patent Citations (2)
Title |
---|
EMBL database, Heidelberg, FRG Emest_Hum20 accession number AA376285 18 April 1997 ADAMS, M.D. ET AL.: "EST88740 HSC172 cells II Homo sapiens cDNA 5' end similar to male sterility 2" * |
EMBL database, Heidelberg, FRG Emhtg accession number AC013828 16 November 1999 BIRREN, B. ET AL.: "Homo sapiens clone RP11-23B7, WORKING DRAFT SEQUENCE, 20 unordered pieces" * |
Also Published As
Publication number | Publication date |
---|---|
CA2374413A1 (en) | 2000-11-30 |
JP2003517288A (en) | 2003-05-27 |
EP1183370A2 (en) | 2002-03-06 |
WO2000071679A2 (en) | 2000-11-30 |
AU5034200A (en) | 2000-12-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2001012662A3 (en) | Membrane associated proteins | |
WO1999061471A3 (en) | Human transmembrane proteins | |
WO2000015793A3 (en) | Human gpcr proteins | |
WO2000018922A3 (en) | Human carbohydrate-associated proteins | |
WO2000034477A3 (en) | Neuron-associated proteins | |
WO1999058692A3 (en) | Human apoptosis associated proteins | |
WO2000009709A3 (en) | Proteases and associated proteins | |
WO2000026245A3 (en) | Human membrane transport proteins | |
WO2000012703A3 (en) | Protein transport-associated molecules | |
WO2000017355A3 (en) | Human cytoskeleton associated proteins | |
WO2000014251A3 (en) | Human transferase proteins | |
WO2001007612A3 (en) | Receptors and associated proteins | |
WO2000052151A3 (en) | Human secretory proteins | |
WO2000078953A3 (en) | Human transport proteins | |
WO2000044900A3 (en) | Nucleic-acid binding proteins | |
WO2000056891A3 (en) | Human transmembrane proteins | |
WO2001044448A3 (en) | Human oxidoreductase proteins | |
WO2000020604A3 (en) | Oxidoreductase molecules | |
WO2000042201A3 (en) | Human peptidases | |
WO2000028045A3 (en) | Human hydrolase proteins | |
WO2000065054A3 (en) | Human membrane-associated proteins | |
WO2000078954A3 (en) | Human transcriptional regulator proteins | |
WO2000008155A3 (en) | Human receptor-associated proteins | |
WO2000001821A3 (en) | Neurotransmission associated proteins | |
WO2000060082A3 (en) | Vesicle associated proteins |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
ENP | Entry into the national phase |
Ref document number: 2374413 Country of ref document: CA Ref country code: JP Ref document number: 2000 620057 Kind code of ref document: A Format of ref document f/p: F Ref country code: CA Ref document number: 2374413 Kind code of ref document: A Format of ref document f/p: F |
|
WWE | Wipo information: entry into national phase |
Ref document number: 09979299 Country of ref document: US |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2000932647 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 2000932647 Country of ref document: EP |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 2000932647 Country of ref document: EP |